Corcept Therapeutics Incorporated
DE ˙ DB ˙ US2183521028
63,24 € ↓ -0,74 (-1,16%)
2026-06-05
DEL PRIS
SecurityDE:HTD / Corcept Therapeutics Incorporated
InstitutionEvanson Asset Management, LLC
Latest Disclosed Ownership13,166 shares
Latest Disclosed Value $ 530,721
Evanson Asset Management, LLC ownership in HTD / Corcept Therapeutics Incorporated

On April 8, 2026 - Evanson Asset Management, LLC filed a 13F-HR form disclosing ownership of 13,166 shares of Corcept Therapeutics Incorporated (DE:HTD) valued at $454,095 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 13,166 shares of Corcept Therapeutics Incorporated. This represents a change in shares of 0.00% during the quarter. The current value of the position is $832,618 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-08 2026-03-31 13F CORCEPT THERAPEUTICS COM 218352102 13,166 0 0.00 531 15.72 0.0285
2026-01-12 2025-12-31 13F CORCEPT THERAPEUTICS COM 218352102 13,166 -1,174 -8.19 458 -61.54 0.0247
2025-10-14 2025-09-30 13F CORCEPT THERAPEUTICS COM 218352102 14,340 -1,378 -8.77 1,192 3.30 0.0672
2025-07-15 2025-06-30 13F CORCEPT THERAPEUTICS COM 218352102 15,718 -5,197 -24.85 1,154 -51.72 0.0717
2025-04-22 2025-03-31 13F CORCEPT THERAPEUTICS COM 218352102 20,915 0 0.00 2,389 126.78 0.1693
2025-01-16 2024-12-31 13F CORCEPT THERAPEUTICS COM 218352102 20,915 -2,529 -10.79 1,054 -2.86 0.0722
2024-10-07 2024-09-30 13F CORCEPT THERAPEUTICS COM 218352102 23,444 0 0.00 1,085 42.44 0.0765
2024-07-12 2024-06-30 13F CORCEPT THERAPEUTICS COM 218352102 23,444 0 0.00 762 28.98 0.0560
2024-04-12 2024-03-31 13F CORCEPT THERAPEUTICS COM 218352102 23,444 -7,560 -24.38 591 -41.41 0.0440
2024-01-18 2023-12-31 13F CORCEPT THERAPEUTICS COM 218352102 31,004 -3,706 -10.68 1,007 6.56 0.0818
2023-10-19 2023-09-30 13F CORCEPT THERAPEUTICS COM 218352102 34,710 -7,640 -18.04 946 0.32 0.0871
2023-07-11 2023-06-30 13F CORCEPT THERAPEUTICS COM 218352102 42,350 2,550 6.41 942 9.28 0.0859
2023-04-13 2023-03-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 862 6.68 0.0853
2023-01-26 2022-12-31 13F/A-1 CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 808 -20.78 0.0869
2023-01-13 2022-12-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 1,020 0.0001
2022-10-12 2022-09-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 1,020 7.82 0.1198
2022-07-13 2022-06-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 946 5.58 0.1041
2022-04-11 2022-03-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 896 13.71 0.0871
2022-01-19 2021-12-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 788 -10.96 0.0701
2021-10-13 2021-09-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 885 1.03 0.0909
2021-07-14 2021-06-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 876 -7.50 0.0911
2021-04-23 2021-03-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 947 -9.03 0.1399
2021-01-22 2020-12-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 1,041 50.22 0.1656
2020-10-13 2020-09-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 693 3.59 0.1253
2020-07-13 2020-06-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 669 41.44 0.1325
2020-04-24 2020-03-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 473 -1.87 0.1128
2020-01-13 2019-12-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 482 -14.39 0.0947
2019-10-11 2019-09-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 563 26.80 0.1156
2019-07-11 2019-06-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 444 -4.93 0.0897
2019-04-09 2019-03-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 467 -12.22 0.0964
2019-01-17 2018-12-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 532 -4.66 0.1215
2018-10-10 2018-09-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 558 -10.86 0.1134
2018-07-11 2018-06-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 626 -4.43 0.1241
2018-04-05 2018-03-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 655 -8.90 0.1348
2018-02-05 2017-12-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 719 -6.38 0.1458
2017-11-14 2017-09-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 768 63.40 0.1642
2017-07-10 2017-06-30 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 470 7.80 0.1082
2017-04-19 2017-03-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 0 0.00 436 50.87 0.1076
2017-02-10 2016-12-31 13F CORCEPT THERAPEUTICS COM 218352102 39,800 17,000 74.56 289 95.27 0.0804
2016-10-18 2016-09-30 13F CORCEPT THERAPEUTICS COM 218352102 22,800 0 0.00 148 19.35 0.0422
2016-07-19 2016-06-30 13F CORCEPT THERAPEUTICS COM 218352102 22,800 0 0.00 124 15.89 0.0375
2016-05-09 2016-03-31 13F CORCEPT THERAPEUTICS COM 218352102 22,800 22,800 0.00 107 0.0366
2016-01-28 2015-12-31 13F CORCEPT THERAPEUTICS COM 218352102 0 0 0 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.